1) Temporal Trends in PCI thru DES era: Insights from 18,641 procedures performed over 12 years. Landes, et al. CCI 2018;92:E262 - E270
Patient demographic changes over 12 years - statistical significant growth shown with Age, Octogenarians, CKD., hemoglobin, creatinine, moderate to severe LVD, and urgent presentation (see attached graphic)
Highlights the changing patient demographic and risk of post procedure complications including AKI. Supporting use of thresholds and contrast management as a resource in these complex procedures.
2) Tsai, et al. Contemporary Incidence, Management, and Long-Term Outcomes of Percutaneous Coronary Interventions for Chronic Coronary Artery Total Occlusions: Insights From the VA CART Program. JACC: CV Interventions. Specific to CTO’s with incidence of 20% patients having CKD in this complex patient population.
CTO’s have become an increasingly common procedure to use DyeVert as part of a kidney care protocol even if pt. doesn’t have CKD pre-procedure due to co-morbidities, length and complexity of procedure, and known high use of contrast dye injected to patients.
<meta name="keywords" content="cardiorenal, cardiology, nephrology, continuing education, UT Health, hypertension, metabolic syndrome, peripheral vascular disease, diabetes, pathophysiologic systems, clinicians, scientists, Cardiorenal syndrome, molecular signatures, cardiac-kidney, cardiorenal syndrome, heart disease, La Cantera, resort, spa, San Antonio, Texas ">